S-1/A XBRL

S-1 AMENDMENT 1 (PRE-EFFECTIVE)

Company: Coeptis Therapeutics Holdings, Inc.
Filed: April 27, 2023
Accession Number: 0001683168-23-002662

View Document ↗ View on SEC.gov ↗